Nuwellis to Participate in the Maxim Group Virtual Healthcare Conference
13 juin 2023 16h15 HE
|
Nuwellis, Inc.
MINNEAPOLIS, June 13, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that...
Nuwellis Announces the Appointment of Mike McCormick to its Board of Directors
05 juin 2023 16h15 HE
|
Nuwellis, Inc.
MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of patients suffering from fluid overload, today...
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22 mai 2023 17h10 HE
|
Nuwellis, Inc.
MINNEAPOLIS, May 22, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that, effective May 19, 2023, the Company’s independent directors approved equity awards under Nuwellis’...
Nuwellis, Inc. Announces First Quarter 2023 Financial Results
09 mai 2023 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, May 09, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial...
Nuwellis, Inc. To Announce First Quarter 2023 Financial Results on May 9, 2023
18 avr. 2023 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, April 18, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that its...
Nuwellis Announces Peer-Reviewed Publication of Clinical Trials Analysis Advocating the Use of Ultrafiltration for Heart Failure Patients Resistant to Diuretics
21 mars 2023 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the...
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 mars 2023 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, March 01, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), today announced that, effective February 23, 2023, the Company’s independent directors approved equity awards under...
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2022 Financial Results
28 févr. 2023 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial...
Nuwellis to Present at the Oppenheimer 33rd Annual Healthcare Conference
23 févr. 2023 16h15 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that...
Clinical Data Supports the Role of Ultrafiltration in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI)
23 févr. 2023 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- A recent editorial published in The Annals of Thoracic Surgery provides additional clinical evidence to support the role that ultrafiltration plays in...